title: Efavirenz-induced photoallergic dermatitis in HIV.
authors.forename: R
authors.initials: R
authors.lastname: Treudler
authors.forename: R
authors.initials: R
authors.lastname: Husak
authors.forename: M
authors.initials: M
authors.lastname: Raisova
authors.forename: C E
authors.initials: CE
authors.lastname: Orfanos
authors.forename: B
authors.initials: B
authors.lastname: Tebbe
mesh_terms: D000368:Aged; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D017454:Dermatitis, Photoallergic / Q000175:diagnosis* / Q000209:etiology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D010641:Phenotype; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz